Impact of the use of azole fungicides, other than as human medicines, on the development of azole‐resistant Aspergillus spp.
Abstract The use of azoles in the European Union and European Economic Area (EU/EEA) other than as human medicines has raised concerns about emergence and spread of azole‐resistant Aspergillus species. EU agencies, with the support of JRC, reviewed the evidence and provided conclusions and recommend...
Saved in:
Main Authors: | European Food Safety Authority (EFSA), European Centre for Disease Prevention and Control (ECDC), European Chemicals Agency (ECHA), European Environment Agency (EEA), European Medicines Agency (EMA), European Commission's Joint Research Centre (JRC) |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | EFSA Journal |
Subjects: | |
Online Access: | https://doi.org/10.2903/j.efsa.2025.9200 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The European Union One Health 2023 Zoonoses report
by: European Food Safety Authority (EFSA), et al.
Published: (2024-12-01) -
Ontology roadmapping and case study implementation
by: European Food Safety Authority (EFSA)
Published: (2024-12-01) -
Statement on the confirmatory data following the Article 12 MRL review for triclopyr
by: European Food Safety Authority (EFSA)
Published: (2024-12-01) -
Hybrid azole-based conjugates as upcoming anticancer and antimicrobial agents
by: Luís M. T. Frija, et al.
Published: (2023-11-01) -
Encapsulating Azolates Within Cationic Metal–Organic Frameworks for High‐Energy‐Density Materials
by: Ning Ding, et al.
Published: (2025-01-01)